Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000091

EVP, Chief Development Officer sold 1,920 shares at $40.66 ($78,070)

  • EVP, Chief Development Officer acquired 3,822 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-03 Grant or award : show line 1 in the form +3,822 74,305 D
2023-02-06 Sale : show line 2 in the form −1,920 $40.66 $78,070 72,385 D
Open-market sales · 1,920 sh · avg $40.66 · $78,070
Loading xslF345X03/edgardoc.xml…